ZA964548B - Antiviral compounds - Google Patents
Antiviral compoundsInfo
- Publication number
- ZA964548B ZA964548B ZA964548A ZA964548A ZA964548B ZA 964548 B ZA964548 B ZA 964548B ZA 964548 A ZA964548 A ZA 964548A ZA 964548 A ZA964548 A ZA 964548A ZA 964548 B ZA964548 B ZA 964548B
- Authority
- ZA
- South Africa
- Prior art keywords
- optionally
- hiv
- antiviral compounds
- linked
- chain
- Prior art date
Links
- 230000000840 anti-viral effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 208000031886 HIV Infections Diseases 0.000 abstract 1
- 241000713772 Human immunodeficiency virus 1 Species 0.000 abstract 1
- 241000713340 Human immunodeficiency virus 2 Species 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 150000002678 macrocyclic compounds Chemical class 0.000 abstract 1
- 150000003956 methylamines Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D255/00—Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00
- C07D255/02—Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00 not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D259/00—Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Communicable Diseases (AREA)
- Veterinary Medicine (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Mechanical Coupling Of Light Guides (AREA)
- Earth Drilling (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9511357.7A GB9511357D0 (en) | 1995-06-06 | 1995-06-06 | Improved antiviral compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA964548B true ZA964548B (en) | 1996-12-12 |
Family
ID=10775536
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA964548A ZA964548B (en) | 1995-06-06 | 1996-06-03 | Antiviral compounds |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5817807A (ko) |
| EP (1) | EP0747368B1 (ko) |
| JP (1) | JP3510955B2 (ko) |
| KR (1) | KR100420725B1 (ko) |
| AT (1) | ATE360623T1 (ko) |
| AU (1) | AU713320B2 (ko) |
| CA (1) | CA2178272C (ko) |
| DE (1) | DE69637040T2 (ko) |
| GB (1) | GB9511357D0 (ko) |
| HK (1) | HK1013995A1 (ko) |
| NO (1) | NO309812B1 (ko) |
| NZ (1) | NZ286711A (ko) |
| TW (1) | TW467744B (ko) |
| ZA (1) | ZA964548B (ko) |
Families Citing this family (54)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6506770B1 (en) | 1996-06-06 | 2003-01-14 | Anormed, Inc. | Antiviral compounds |
| TW381385B (en) * | 1997-08-20 | 2000-02-01 | Advantest Corp | Signal transmission circuit, CMOS semiconductor device and circuit board |
| WO2000043004A1 (en) * | 1999-01-26 | 2000-07-27 | Fox Chase Cancer Center | 1,4,8,11-tetraazacyclotetradecane derivatives as radiodiganostic agents and their use in determining hypoxia and radioresistance of tumors |
| US6365583B1 (en) | 1999-02-02 | 2002-04-02 | Anormed, Inc. | Methods to enhance white blood cell count |
| EP1035117A1 (en) | 1999-03-08 | 2000-09-13 | Dsm N.V. | Method for preparing melamine from urea |
| JP2003524620A (ja) * | 1999-03-24 | 2003-08-19 | アノーメッド インコーポレイティド | ケモカインレセプター結合複素環化合物 |
| US6750348B1 (en) | 1999-03-24 | 2004-06-15 | Anormed, Inc. | Chemokine receptor binding heterocyclic compounds |
| JP2002543126A (ja) * | 1999-05-03 | 2002-12-17 | スミスクライン・ビーチャム・コーポレイション | Ｃｘｃｒ−４受容体アンタゴニスト−トロンボポエチン模倣物 |
| EP1244648B1 (en) | 1999-12-17 | 2009-04-15 | Genzyme Corporation | Chemokine receptor binding heterocyclic compounds |
| JP2004508421A (ja) * | 2000-09-15 | 2004-03-18 | アノーメッド インコーポレイティド | ケモカインレセプター結合性ヘテロ環式化合物 |
| BR0113932A (pt) | 2000-09-15 | 2003-06-24 | Anormed Inc | Compostos heterocìclicos que se ligam ao receptor da quimiocina |
| PL360932A1 (en) * | 2000-09-15 | 2004-09-20 | Anormed Inc. | Chemokine receptor binding heterocyclic compounds |
| US7052676B2 (en) * | 2000-09-26 | 2006-05-30 | The Regents Of The University Of Michigan | Methods for inhibition of HIV replication using a small molecule inhibitor |
| PT1411918E (pt) * | 2001-07-31 | 2012-03-06 | Genzyme Global S A R L | Métodos para mobilizar células progenitoras/estaminais |
| US7169750B2 (en) * | 2001-07-31 | 2007-01-30 | Anormed, Inc. | Methods to mobilize progenitor/stem cells |
| KR20040044909A (ko) * | 2001-09-12 | 2004-05-31 | 아노르메드 인코포레이티드 | 거울상이성체적으로 순수한 아미노-치환된 융합비사이클릭 환의 합성 |
| US7354932B2 (en) | 2001-12-21 | 2008-04-08 | Anormed, Inc. | Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| JP4556020B2 (ja) * | 2001-12-21 | 2010-10-06 | ジェンザイム・コーポレーション | 高い有効性を有するケモカインレセプタ結合複素環式化合物 |
| EP1613613B1 (en) | 2003-04-11 | 2021-06-02 | Genzyme Corporation | Cxcr4 chemokine receptor binding compounds |
| EP2374804A1 (en) * | 2003-04-22 | 2011-10-12 | Genzyme Corporation | Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| US7501518B2 (en) * | 2003-04-22 | 2009-03-10 | Genzyme Corporation | Methods of making 2,6-diaryl piperidine derivatives |
| WO2004111077A1 (en) | 2003-06-18 | 2004-12-23 | Tranzyme Pharma Inc. | Macrocyclic antagonists of the motilin receptor |
| US7498346B2 (en) * | 2003-12-11 | 2009-03-03 | Genzyme Corporation | Chemokine receptor binding compounds |
| US7491735B2 (en) * | 2003-12-11 | 2009-02-17 | Genzyme Corporation | Chemokine receptor binding compounds |
| BRPI0508703B8 (pt) * | 2004-03-15 | 2021-05-25 | Anormed Inc | processo para a síntese de um antagonista de cxcr4 |
| US20060035829A1 (en) * | 2004-08-13 | 2006-02-16 | Anormed Inc. | Chemokine combinations to mobilize progenitor/stem cells |
| TW200619206A (en) * | 2004-09-29 | 2006-06-16 | Anormed Inc | Chemokine-binding heterocyclic compound salts, and methods of use thereof |
| WO2006138350A2 (en) * | 2005-06-15 | 2006-12-28 | Anormed Inc. | Chemokine receptor binding compounds |
| CN101309690A (zh) * | 2005-08-16 | 2008-11-19 | 阿诺麦德股份有限公司 | 趋化因子受体结合化合物 |
| WO2007022523A2 (en) | 2005-08-19 | 2007-02-22 | Genzyme Corporation | Methods to enhance chemotherapy |
| CA2643209A1 (en) | 2006-02-24 | 2007-09-20 | Genzyme Corporation | Methods for increasing blood flow and/or promoting tissue regeneration |
| RU2009108289A (ru) * | 2006-08-07 | 2010-09-20 | Джензим Корпорейшн (Us) | Комбинированная терапия |
| US8921328B2 (en) | 2010-09-14 | 2014-12-30 | Glycomimetics, Inc. | E-selectin antagonists |
| MX365242B (es) | 2011-05-16 | 2019-05-28 | Genzyme Corp | El uso del antagonista cxcr4: 1,1´-[1,4-fenileno-bis-(metileno)-bi s-1, 4, 8, 11-tetraazaciclotetradecano (plerixaflor) para el tratamiento del síndrome de whim. |
| ES2655443T7 (es) | 2011-12-22 | 2021-03-22 | Glycomimetics Inc | Compuestos antagonistas de E-selectina |
| CA2891514C (en) | 2012-12-07 | 2020-08-25 | Glycomimetics, Inc. | Compounds, compositions and methods using e-selectin antagonists for mobilization of hematopoietic cells |
| CN107108679B (zh) | 2014-12-03 | 2020-10-23 | 糖模拟物有限公司 | E-选择蛋白和cxcr4趋化因子受体的异双官能抑制剂 |
| EP3302710A4 (en) | 2015-06-03 | 2019-02-20 | The University of Queensland | MOBILIZERS AND USE THEREOF |
| EP3389634B1 (en) | 2015-12-14 | 2021-10-06 | X4 Pharmaceuticals, Inc. | Methods for treating cancer |
| EP3389652B1 (en) | 2015-12-14 | 2022-09-28 | X4 Pharmaceuticals, Inc. | Methods for treating cancer |
| SI3393468T1 (sl) | 2015-12-22 | 2023-01-31 | X4 Pharmaceuticals, Inc. | Postopki za zdravljenje bolezni imunske pomanjkljivosti |
| WO2017151708A1 (en) | 2016-03-02 | 2017-09-08 | Glycomimetics, Inc. | Methods for the treatment and/or prevention of cardiovescular disease by inhibition of e-selectin |
| CN109153722A (zh) | 2016-04-08 | 2019-01-04 | X4 制药有限公司 | 用于治疗癌症的方法 |
| CN116554168A (zh) | 2016-06-21 | 2023-08-08 | X4 制药有限公司 | Cxcr4抑制剂及其用途 |
| CN109641838A (zh) | 2016-06-21 | 2019-04-16 | X4 制药有限公司 | Cxcr4抑制剂及其用途 |
| CN109640988A (zh) | 2016-06-21 | 2019-04-16 | X4 制药有限公司 | Cxcr4抑制剂及其用途 |
| US11433086B2 (en) | 2016-08-08 | 2022-09-06 | Glycomimetics, Inc. | Combination of T-cell checkpoint inhibitors with inhibitors of e-selectin or CXCR4, or with heterobifunctional inhibitors of both E-selectin and CXCR4 |
| JP7069136B2 (ja) | 2016-10-07 | 2022-05-17 | グリコミメティクス， インコーポレイテッド | 極めて強力な多量体ｅ－セレクチンアンタゴニスト |
| JP7272956B2 (ja) | 2017-03-15 | 2023-05-12 | グリコミメティクス， インコーポレイテッド | Ｅ－セレクチンアンタゴニストとしてのガラクトピラノシル－シクロヘキシル誘導体 |
| US11712446B2 (en) | 2017-11-30 | 2023-08-01 | Glycomimetics, Inc. | Methods of mobilizing marrow infiltrating lymphocytes and uses thereof |
| CN111566117A (zh) | 2017-12-29 | 2020-08-21 | 糖模拟物有限公司 | E-选择蛋白和半乳凝素-3的异双功能抑制剂 |
| AU2019230013A1 (en) | 2018-03-05 | 2020-09-10 | Glycomimetics, Inc. | Methods for treating acute myeloid leukemia and related conditions |
| US10548889B1 (en) | 2018-08-31 | 2020-02-04 | X4 Pharmaceuticals, Inc. | Compositions of CXCR4 inhibitors and methods of preparation and use |
| US11845771B2 (en) | 2018-12-27 | 2023-12-19 | Glycomimetics, Inc. | Heterobifunctional inhibitors of E-selectin and galectin-3 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5021409A (en) * | 1989-12-21 | 1991-06-04 | Johnson Matthey Plc | Antiviral cyclic polyamines |
| GB9105489D0 (en) * | 1991-03-15 | 1991-05-01 | Johnson Matthey Plc | Improvements in chemical compounds |
| GB9126677D0 (en) * | 1991-12-16 | 1992-02-12 | Johnson Matthey Plc | Improvements in chemical compounds |
| GB9400411D0 (en) * | 1994-01-11 | 1994-03-09 | Johnson Matthey Plc | Improvements in chemical compounds |
| US6506770B1 (en) * | 1996-06-06 | 2003-01-14 | Anormed, Inc. | Antiviral compounds |
-
1995
- 1995-06-06 GB GBGB9511357.7A patent/GB9511357D0/en active Pending
-
1996
- 1996-05-21 EP EP96303608A patent/EP0747368B1/en not_active Expired - Lifetime
- 1996-05-21 AT AT96303608T patent/ATE360623T1/de not_active IP Right Cessation
- 1996-05-21 DE DE69637040T patent/DE69637040T2/de not_active Expired - Fee Related
- 1996-05-23 AU AU52455/96A patent/AU713320B2/en not_active Ceased
- 1996-05-31 NZ NZ286711A patent/NZ286711A/en not_active IP Right Cessation
- 1996-06-03 ZA ZA964548A patent/ZA964548B/xx unknown
- 1996-06-04 JP JP14179296A patent/JP3510955B2/ja not_active Expired - Fee Related
- 1996-06-05 KR KR1019960019946A patent/KR100420725B1/ko not_active IP Right Cessation
- 1996-06-05 CA CA002178272A patent/CA2178272C/en not_active Expired - Fee Related
- 1996-06-05 NO NO962325A patent/NO309812B1/no not_active IP Right Cessation
- 1996-06-06 US US08/659,500 patent/US5817807A/en not_active Expired - Lifetime
- 1996-06-06 TW TW085106777A patent/TW467744B/zh not_active IP Right Cessation
-
1998
- 1998-12-23 HK HK98115250A patent/HK1013995A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| NO309812B1 (no) | 2001-04-02 |
| DE69637040D1 (de) | 2007-06-06 |
| HK1013995A1 (en) | 1999-09-17 |
| EP0747368B1 (en) | 2007-04-25 |
| KR100420725B1 (ko) | 2004-06-12 |
| AU713320B2 (en) | 1999-11-25 |
| NO962325D0 (no) | 1996-06-05 |
| ATE360623T1 (de) | 2007-05-15 |
| GB9511357D0 (en) | 1995-08-02 |
| DE69637040T2 (de) | 2007-12-27 |
| EP0747368A1 (en) | 1996-12-11 |
| US5817807A (en) | 1998-10-06 |
| JP3510955B2 (ja) | 2004-03-29 |
| NZ286711A (en) | 1998-02-26 |
| CA2178272C (en) | 2003-12-16 |
| NO962325L (no) | 1996-12-09 |
| JPH0912560A (ja) | 1997-01-14 |
| CA2178272A1 (en) | 1996-12-07 |
| AU5245596A (en) | 1996-12-19 |
| KR970000250A (ko) | 1997-01-21 |
| TW467744B (en) | 2001-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA964548B (en) | Antiviral compounds | |
| ZA9811576B (en) | Anilide derivative, production and use thereof. | |
| UA39099C2 (uk) | Циклічні азотовмісні похідні, суміш їх ізомерів або окремі ізомери, або їх солі | |
| AU6329794A (en) | Nitrogen-containing spirocycles | |
| CA2179530A1 (en) | Cyclic polyamines | |
| MY110897A (en) | Aromatic-linked polyamine macrocyclic compounds with anti-hiv activity | |
| IL109720A0 (en) | N-alkylthio polyamide derivatives as radioprotective agents | |
| GR3027677T3 (en) | Sulfur-containing derivatives of 2-cyano-1,3-diones and their use as herbicides. | |
| DK0463969T3 (da) | Hidtil ukendte 4-aminosmørsyreforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske præparater, som indeholder dem | |
| IL86381A0 (en) | Oxetanocins and pharmaceutical compositions containing the same | |
| AU9281198A (en) | Benzofuran derivatives | |
| ES2155460T3 (es) | Sintesis en fase solida de oligorribonucleotidos. | |
| BR9808770A (pt) | Conjugado medicamentoso, método para suaprodução e seu uso | |
| IL111527A0 (en) | 1,5-Diiodo-2(s)-alkoxy (or benzyloxy)-3-oxa-pentanes and their preparation | |
| AU2539792A (en) | Benzopyran intermediates | |
| GR3025056T3 (en) | Nitroxyalkylamide derivative. | |
| MY111508A (en) | Process for the production of c-substituted diethylenetriamines | |
| SI0746556T1 (en) | Tricyclic compounds having affinity for the 5-ht1a receptor | |
| UA70975C2 (uk) | Похідні 1,4-діарил-2-фтор-1-бутен-3-олу, спосіб їх одержання та способи одержання похідних 1,4-діарил-2-фтор-1,3-бутадієну і 1,4-діарил-2-фтор-2-бутену | |
| ZA92537B (en) | New process for preparing 2'-(diethylamino)rifamycin p(p/dea) |